AzTrials
AzTrials

AnxietyNCT07453615

Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children

A study testing AI-Generated Storytelling Video and Standard Clinic Care in people with Anxiety and Fear Anxiety, run by Antalya Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the effectiveness of an AI-generated therapeutic storytelling video on pre-procedural anxiety and fear levels in children aged 4 to 10 years undergoing their first Skin Prick Test (SPT). Read more about this study

Who is it for?
Ages 4 to 10 years
Conditions the study is for
Anxiety, Fear Anxiety, Allergic Rhinitis
What is being tested?
AI-Generated Storytelling Video and Standard Clinic Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
102 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Mar 2026to 9 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children aged between 4 and 10 years (from 4th birthday to 11th birthday).
  • Children undergoing a Skin Prick Test (SPT) for the first time.
  • Presence of suspected Allergic Rhinitis and/or Asthma.
  • Cognitive ability to understand Turkish, follow the video story, and interpret visual assessment scales.
  • Parents with internet access to view the digital content.
  • Obtained parental informed consent and child assent (for ages 7 and above)

Who cannot join

  • Previous experience with Skin Prick Testing or a history of frequent medical procedures (e.g., frequent blood draws, surgeries) due to chronic illness.
  • Diagnosed with Autism Spectrum Disorder, severe ADHD(attention deficit hyperactivity disorder), intellectual disability, or severe psychiatric conditions preventing cooperation.
  • Significant visual or hearing impairments that prevent engagement with the video content.
  • Use of anxiolytics, sedatives, or medications affecting cognitive functions within the last 24 hours.
  • Chronic health problems (e.g., malignancy, immunodeficiency) that may elevate baseline anxiety levels.
  • Patients undergoing SPT for suspected Food Allergy, Drug Allergy, or Bee Venom Allergy.
  • For the intervention group: Failure to watch the video or answering the three "validation questions" incorrectly on the procedure day.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Health Sciences University Antalya Training and Research Hospital

    Antalya, 07030

Other trials in Turkey (Türkiye)

About this study

Official title: AI-Based Video-Mediated Cognitive Preparation in Skin Prick Testing: A Prospective, Randomized Controlled Trial

This study evaluates the effectiveness of an AI-generated therapeutic storytelling video on pre-procedural anxiety and fear levels in children aged 4 to 10 years undergoing their first Skin Prick Test (SPT). The study aims to determine if watching a cognitive preparation video at home prior to the appointment reduces anxiety compared to standard care. Participants will be randomized into two groups: an intervention group watching the AI-generated video and a control group receiving standard clinic care

Read the detailed description

Skin Prick Testing (SPT) is a common diagnostic procedure in pediatric allergy clinics that often induces significant pre-procedural anxiety and acute needle fear in children. While digital distraction tools are becoming common during procedures, pre-procedural cognitive preparation strategies are limited. This randomized controlled trial investigates the impact of cognitive preparation using an AI-assisted therapeutic storytelling video.

+4

The study utilizes a prospective, single-blind, randomized controlled design. A total of 100 children (aged 4-10) with suspected respiratory allergies undergoing their first SPT will be randomized (1:1 ratio) into intervention and control groups.

  • 3
  • Intervention Group: Children will watch an AI-generated therapeutic storytelling video at home (the evening the appointment is made and the night before the procedure). The video, featuring characters "Ilay and Doctor Ipek", is designed to cognitively prepare the child for the procedure using age-appropriate metaphors without traumatizing elements.
  • Control Group: Children will receive the clinic's standard routine care and verbal information.
  • 4

Baseline anxiety is assessed using the Spence Preschool Anxiety Scale or Spence Children's Anxiety Scale. Procedural fear and pain are evaluated using the Children's Fear Scale (CFS) and the Wong-Baker FACES Scale. Behavioral responses during the procedure are observed and scored by a blinded nurse using the Children's Emotional Manifestation Scale (CEMS). The primary hypothesis is that AI-based cognitive preparation will significantly reduce pre-procedural anxiety and fear, and improve procedural compliance compared to standard care

Being tested
AI-Generated Storytelling Video, Standard Clinic Care
Keywords
Skin Prick Test, Artificial Intelligence, Cognitive Preparation, Storytelling
Medical subject headings
Anxiety Disorders, Rhinitis, Allergic, Asthma, Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI-Generated Storytelling VideoBehavioural

    A customized, AI-assisted animated story video featuring child-friendly characters (Lilly and Doctor Sunny) explaining the Skin Prick Test procedure. It is watched at home the evening the appointment is made and the night before the procedure to provide cognitive preparation.

  • Standard Clinic CareOther

    Routine verbal explanation of the procedure provided by the clinic staff.

Study groups in NCT07453615
Study groupRoleWhat they receive
AI-Video Intervention GroupExperimentalParticipants in this group will watch an AI-generated therapeutic storytelling video about the Skin Prick Test procedure at home, twice before their clinical appointment
Receives: Behavioral: AI-Generated Storytelling Video
Standard Care GroupActive comparatorParticipants in this group will receive standard routine verbal information and standard clinic care prior to the procedure, without any digital preparatory intervention.
Receives: Other: Standard Clinic Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Baseline Anxiety Level

    Assessed using the Spence Preschool Anxiety Scale (for ages 4-6) or Spence Children's Anxiety Scale (for ages 7-10). These validated scales measure general anxiety symptoms. Higher scores indicate higher levels of anxiety.

    Measured: Baseline

  2. Acute Procedural Fear Level

    Assessed using the Children's Fear Scale (CFS). This scale consists of five facial expressions representing a range from neutral (0) to extreme fear (4). Higher scores indicate higher levels of acute fear.

    Measured: Immediately post-procedure

Secondary outcomes (2)
  1. Behavioral Distress During Procedure

    Assessed by a linded observer physician using the Children's Emotional Manifestation Scale (CEMS). It evaluates facial expression, vocalization, activity, interaction, and level of cooperation. Total scores range from 5 to 25, with higher scores indicating more negative emotional behaviors and higher distress

    Measured: Periprocedural

  2. Self-Reported Procedural Pain

    Assessed using the Wong-Baker FACES Pain Rating Scale. The scale consists of six faces representing pain intensity, scored from 0 to 10. Higher scores indicate greater pain

    Measured: within the first 5 minutes of the 15-minute SPT reading period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Mar 2026
  2. Study start15 Mar 2026
  3. Primary completion9 Jul 2026
  4. Study completion9 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Outcomes assessor
Enrolment
102 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07453615
Sponsor's protocol ID
2026-36
Status last verified
Mar 2026
First submitted
2 Mar 2026
Last updated
12 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data (IPD) that underlie the results reported in the future published article will be shared. This includes demographic characteristics, anxiety scale scores, fear scale scores, behavioral distress scores, and pain scores, strictly after removing any personally identifiable information

Questions about this trial

What is this clinical trial studying?

A study testing AI-Generated Storytelling Video and Standard Clinic Care in people with Anxiety and Fear Anxiety, run by Antalya Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Baseline Anxiety Level (time frame: Baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in